
Scientists are debating whether we need to understand ageing in greater detail before developing treatments, or whether progress will come faster by testing new ideas and learning from the results.
How much do we really need to know about ageing before we can develop treatments that help people stay healthier for longer?
It is a question at the heart of modern ageing research, and one that is sparking debate among scientists.
While our understanding of why and how we age has advanced considerably over recent decades, there is still much we don’t know. The biological processes involved are complex, closely connected and difficult to separate. Researchers are still working to establish which mechanisms matter most, how they influence one another and which changes actually drive the ageing process.
But does that mean we should wait until we have all the answers before trying to develop treatments?
Not according to a growing engineering-led approach to ageing research, which argues that practical experimentation and learning through trial and error could be just as important as understanding the science.
Learning by doing could speed up progress
A recent discussion published by Fight Aging! highlights the divide between those who believe a deeper scientific understanding must come first and those who argue that researchers should be more willing to turn promising discoveries into practical treatments.
The argument is that waiting for a complete understanding of ageing could slow progress unnecessarily.
In many areas of science and technology, major breakthroughs have come from building, testing, failing and trying again – often before researchers fully understood why something worked.
Aging research could benefit from the same approach.
One example is the growing interest in senescent cells. These are damaged or dysfunctional cells that stop dividing but remain in the body. Their accumulation is associated with a range of age-related problems.
Experiments in older mice have shown that clearing some of these cells can produce significant improvements in health and aspects of age-related decline.
These findings surprised many researchers and helped attract substantial new investment and interest in the field.
The argument is simple: without researchers being prepared to test the idea, the potential benefits might still be largely theoretical.
Rethinking how we measure aging
The debate also raises important questions about some of the concepts widely used in ageing research.
One example is ‘biological age’ – a term often used to describe how old someone’s body appears to be compared with their actual age.
Although biological aging tests and so-called aging clocks have become increasingly popular, there are concerns about how accurately they measure meaningful changes in health.
A person’s biological age might appear to improve according to an aging clock, but that does not necessarily mean their health, physical abilities or life expectancy have improved.
Researchers need to look beyond numbers and measurements and establish whether treatments produce real improvements in how people function and feel.
Healthier lives and longer lives should go together
Another important issue is the distinction sometimes made between extending healthspan and extending lifespan.
Healthspan refers to the number of years a person lives in good health, while lifespan refers to how long they live.
Some researchers and funding organisations have traditionally placed greater emphasis on extending healthy years rather than increasing overall lifespan.
However, the two goals do not necessarily compete.
In fact, improving health and reducing the impact of age-related disease could also help people
live longer.
Rather than treating healthspan and lifespan as opposing goals, researchers should consider how improvements in one can support the other.
Is there really one cause of ageing?
For many years, scientists have searched for a single underlying cause of ageing.
Different theories have focused on cellular senescence, damage to DNA, changes in mitochondria, declining stem cell function and other biological processes.
However, ageing is unlikely to be explained by one mechanism alone.
The human body is an incredibly complicated system, with many biological processes influencing one another. Blocking one source of damage may help address a particular age-related problem without significantly changing the overall ageing process.
This means researchers need to be careful about assuming that identifying or targeting one mechanism will provide a complete solution.
Finding the right balance
The wider message from the debate is that ageing research needs both scientific understanding and practical innovation.
A better understanding of the biology of ageing is essential, but waiting for every question to be answered before developing and testing treatments could hold back progress.
Some experiments will fail. Others may reveal unexpected results or open up entirely new areas of research.
That is part of the scientific process.
The challenge is to build on what researchers already know, test promising approaches and carefully measure whether they produce meaningful benefits.
Ultimately, the goal is not simply to find ways to change biological measurements or make people appear younger on paper.
It is to discover treatments that help people remain healthier, stronger and more active for longer.
\And getting there may require scientists to do more than understand aging, they may need to be prepared to engineer their way towards solutions.



